Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Wegovy belongs to a drug class called glucagon-like peptide-1 (GLP-1 ... Retail price refers to the manufacturer’s published list price and is up to date as of 3/2023. Retail and discounted ...

Last week, the FDA determined the shortage of Eli Lilly tirzepatide injection, a glucagon-like peptide 1 (GLP-1 ... a company ...

ARGEN, by Fluence Analytics, offers scientists the instruments they need to effortlessly surveil changes in the normalized ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

The first patient has been dosed in a trial assessing the peptide-drug conjugate CBX-12 in patients with platinum-resistant or refractory ovarian cancer, according to a press release from Cybrexa ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

However, the FDA determined yesterday that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1 ...

On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 ...

Tissue engineering and regenerative studies are areas of scientific investigation that aim to repair or replace damaged tissues and organs. Scientists speculate that peptide blends might play a key ...

Using peptides and polymer chains, scientists at Northwestern University have developed a new type of flexible nano-ribbon material that can switch polarity in response to very low external voltages, ...